HR 3682
117th Congress
House
Health
Improving Transparency to Lower Drug Costs Act of 2021
Introduced: June 1, 2021
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 2, 2021
Referred to the Subcommittee on Health.
Jun 1, 2021
Referred to the Subcommittee on Health.
Jun 1, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 1, 2021
Introduced in House
Plain-English summary
Improving Transparency to Lower Drug Costs Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1